Category: Psoriasis

Updates in Psoriasis Management 2021

J Clin Aesthet Dermatol 2021;14(7 Suppl 1):S7–S19. A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues: Each year, Maui Derm seeks to bring to the podium the most up-to-date and cutting-edge scientific and clinical developments in the field of dermatology. Despite being a fully virtual event, Maui Derm 2021


The Serum Level of Oxidative Stress and Antioxidant Markers in Patients with Psoriasis: A Cross-sectional Study

J Clin Aesthet Dermatol. 2021;14(7):38–41. by Safoura Shakoei, MD; Manouchehr Nakhjavani, MD; Hossein Mirmiranpoor, MD; Mohana Alinejad Motlagh, MD; Arghavan Azizpour, MD; and Robabeh Abedini, MD Drs. Shakoei and Motlagh are with the Department of Dermatology at Imam Khomeini Hospital, Tehran University of Medical Sciences in Tehran, Iran. Drs. Nakhjavani and Mirmiranpoor are with the


Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review

J Clin Aesthet Dermatol. 2021;14(6):55–59. by Donovan G. Kearns, BA; Shelley Uppal, MD; Vipawee S. Chat, BA; and Jashin J. Wu, MD Mr. Kearns is with Loma Linda University School of Medicine in Loma Linda, California. Dr. Uppal is with Albany Medical College School of Medicine in Albany, New York. Ms. Chat is with the


Selected Abstracts from MauiDerm 2021 for Dermatologists

J Clin Aesthet Dermatol. 2021;14(5 Suppl 1):S8–S30. © µ µ ? A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues:  The 2021 edition of the Maui Derm for Dermatologists meeting had a variety of clinical and scientific data presented, but not just at the podium. A wide range of clinically